Plasminogen activator inhibitor-1
- PMID: 15379715
- DOI: 10.2174/0929867043364595
Plasminogen activator inhibitor-1
Abstract
Plasminogen activator inhibitor-1 (PAI-1) is an important component of the plasminogen/plasmin system as it is the main inhibitor of tissue-type and urokinase-type plasminogen activator. Consequently, PAI-1 plays an important role in cardiovascular diseases (mainly through inhibition of t-PA) and in cell migration and tumor development (mainly through inhibition of u-PA). As a member of the serpin superfamily, PAI-1 shares important structural properties with other serpins. However, PAI-1 also exhibits unique conformational and functional properties. The current paper provides an overview of the knowledge on PAI-1 gathered since its discovery two decades ago. We are discussing (a) its structural properties and their subsequent association with the functional properties, (b) its role in a wide variety of (patho)physiological processes and (c) a number of strategies to interfere with its functional properties eventually aiming at pharmacological modulation of this risk factor.
Similar articles
-
The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors.Thromb Haemost. 2004 Mar;91(3):425-37. doi: 10.1160/TH03-12-0764. Thromb Haemost. 2004. PMID: 14983217 Review.
-
The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors.Verh K Acad Geneeskd Belg. 2006;68(3):179-98. Verh K Acad Geneeskd Belg. 2006. PMID: 16796017 Review.
-
Use of mouse models to study plasminogen activator inhibitor-1.Methods Enzymol. 2011;499:77-104. doi: 10.1016/B978-0-12-386471-0.00005-5. Methods Enzymol. 2011. PMID: 21683250
-
Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin.Semin Thromb Hemost. 2013 Jun;39(4):356-64. doi: 10.1055/s-0033-1334487. Epub 2013 Mar 16. Semin Thromb Hemost. 2013. PMID: 23504606 Review.
-
Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms.Biochim Biophys Acta. 1997 Feb 8;1337(2):257-66. doi: 10.1016/s0167-4838(96)00173-2. Biochim Biophys Acta. 1997. PMID: 9048903
Cited by
-
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337. Int J Mol Sci. 2021. PMID: 35008762 Free PMC article. Review.
-
Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor.Int J Hypertens. 2011;2011:346985. doi: 10.4061/2011/346985. Epub 2011 May 22. Int J Hypertens. 2011. PMID: 21747976 Free PMC article.
-
Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L54-L68. doi: 10.1152/ajplung.00579.2016. Epub 2017 Aug 31. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 28860148 Free PMC article.
-
The Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and the Risk of Alzheimer's Disease.Am J Alzheimers Dis Other Demen. 2017 Sep;32(6):342-346. doi: 10.1177/1533317517705223. Epub 2017 May 3. Am J Alzheimers Dis Other Demen. 2017. PMID: 28466654 Free PMC article.
-
Plasminogen Activator Inhibitor-1 4G/5G (rs1799889) Polymorphism in Chinese Patients with Diabetes Mellitus and Hypertension.Diabetes Metab Syndr Obes. 2023 Apr 22;16:1133-1147. doi: 10.2147/DMSO.S410682. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37122677 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous